Annual CFF:
$191.24M+$116.87M(+157.16%)Summary
- As of today, RYTM annual cash from financing is $191.24 million, with the most recent change of +$116.87 million (+157.16%) on December 31, 2024.
- During the last 3 years, RYTM annual cash from financing has risen by +$24.76 million (+14.87%).
- RYTM annual cash from financing is now -10.56% below its all-time high of $213.83 million, reached on December 31, 2022.
Performance
RYTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$189.30M+$190.19M(+21393.70%)Summary
- As of today, RYTM quarterly cash from financing is $189.30 million, with the most recent change of +$190.19 million (+21393.70%) on September 30, 2025.
- Over the past year, RYTM quarterly cash from financing has increased by +$186.81 million (+7496.35%).
- RYTM quarterly cash from financing is now at all-time high.
Performance
RYTM Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$259.24M+$186.81M(+257.92%)Summary
- As of today, RYTM TTM cash from financing is $259.24 million, with the most recent change of +$186.81 million (+257.92%) on September 30, 2025.
- Over the past year, RYTM TTM cash from financing has increased by +$103.90 million (+66.89%).
- RYTM TTM cash from financing is now -16.42% below its all-time high of $310.18 million, reached on June 30, 2018.
Performance
RYTM TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RYTM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +157.2% | +7496.4% | +66.9% |
| 3Y3 Years | +14.9% | +19.4% | +31.9% |
| 5Y5 Years | +17.0% | +10000.0% | +58.5% |
RYTM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -10.6% | +157.2% | at high | >+9999.0% | at high | +257.9% |
| 5Y | 5-Year | -10.6% | +9419.3% | at high | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | -10.6% | >+9999.0% | at high | >+9999.0% | -16.4% | >+9999.0% |
RYTM Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $189.30M(>+9900.0%) | $259.24M(+257.9%) |
| Jun 2025 | - | -$889.00K(-102.7%) | $72.43M(-67.0%) |
| Mar 2025 | - | $32.50M(-15.2%) | $219.50M(+14.8%) |
| Dec 2024 | $191.24M(+157.2%) | $38.33M(+1438.0%) | $191.24M(+23.1%) |
| Sep 2024 | - | $2.49M(-98.3%) | $155.34M(-31.2%) |
| Jun 2024 | - | $146.18M(+3345.2%) | $225.89M(+186.9%) |
| Mar 2024 | - | $4.24M(+75.1%) | $78.74M(+5.9%) |
| Dec 2023 | $74.37M(-65.2%) | $2.42M(-96.7%) | $74.37M(-16.7%) |
| Sep 2023 | - | $73.04M(+7669.2%) | $89.31M(-48.9%) |
| Jun 2023 | - | -$965.00K(-625.6%) | $174.83M(-18.0%) |
| Mar 2023 | - | -$133.00K(-100.8%) | $213.30M(-0.2%) |
| Dec 2022 | $213.83M(+28.4%) | $17.36M(-89.0%) | $213.83M(+8.8%) |
| Sep 2022 | - | $158.56M(+322.8%) | $196.56M(+411.7%) |
| Jun 2022 | - | $37.50M(+9298.5%) | $38.41M(+2866.2%) |
| Mar 2022 | - | $399.00K(+299.0%) | $1.29M(-99.2%) |
| Dec 2021 | $166.48M(+8186.8%) | $100.00K(-75.8%) | $166.48M(-0.2%) |
| Sep 2021 | - | $413.00K(+7.8%) | $166.80M(-0.2%) |
| Jun 2021 | - | $383.00K(-99.8%) | $167.09M(+0.1%) |
| Mar 2021 | - | $165.59M(>+9900.0%) | $166.89M(+8207.0%) |
| Dec 2020 | $2.01M | $420.00K(-39.9%) | $2.01M(-98.8%) |
| Sep 2020 | - | $699.00K(+282.0%) | $163.55M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $183.00K(-74.1%) | $163.55M(-0.2%) |
| Mar 2020 | - | $707.00K(-99.6%) | $163.87M(+0.2%) |
| Dec 2019 | $163.47M(-0.7%) | $161.96M(>+9900.0%) | $163.47M(+9724.2%) |
| Sep 2019 | - | $697.00K(+40.0%) | $1.66M(-22.2%) |
| Jun 2019 | - | $498.00K(+57.6%) | $2.14M(-98.7%) |
| Mar 2019 | - | $316.00K(+106.5%) | $165.00M(+0.2%) |
| Dec 2018 | $164.69M(-1.5%) | $153.00K(-87.0%) | $164.69M(-43.2%) |
| Sep 2018 | - | $1.17M(-99.3%) | $290.19M(-6.4%) |
| Jun 2018 | - | $163.36M(>+9900.0%) | $310.18M(+111.3%) |
| Mar 2018 | - | $0.00(-100.0%) | $146.82M(-12.2%) |
| Dec 2017 | $167.20M(>+9900.0%) | $125.66M(+493.7%) | $167.20M(+302.5%) |
| Sep 2017 | - | $21.16M(>+9900.0%) | $41.54M(+103.9%) |
| Jun 2017 | - | $0.00(-100.0%) | $20.38M(0.0%) |
| Mar 2017 | - | $20.38M(>+9900.0%) | $20.38M(+39.2%) |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Jun 2016 | - | $0.00(0.0%) | $14.64M(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $14.64M(0.0%) |
| Dec 2015 | $41.71M(+462.2%) | - | - |
| Dec 2015 | - | $14.64M | $14.64M |
| Dec 2014 | $7.42M(-62.7%) | - | - |
| Dec 2013 | $19.88M(-11.4%) | - | - |
| Dec 2012 | $22.44M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of RYTM is $191.24M
What is the all-time high annual cash from financing for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual cash from financing is $213.83M
What is Rhythm Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, RYTM annual cash from financing has changed by +$116.87M (+157.16%)
What is Rhythm Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of RYTM is $189.30M
What is the all-time high quarterly cash from financing for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly cash from financing is $189.30M
What is Rhythm Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, RYTM quarterly cash from financing has changed by +$186.81M (+7496.35%)
What is Rhythm Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of RYTM is $259.24M
What is the all-time high TTM cash from financing for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM cash from financing is $310.18M
What is Rhythm Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, RYTM TTM cash from financing has changed by +$103.90M (+66.89%)